
US-based biotechnology royalty aggregator XOMA has announced that it has gained the royalty and milestone rights for two assets from …

Novo Nordisk has announced its purchase of a type 2 diabetes diabetes program in a deal with biotech firm Xoma …
US biotech Xoma has decided to rely on a contract manufacturing organisation for its Phase III and commercial production needs, …
Xoma has instigated a major cull of its workforce, with 144 jobs to go in a move that will cut …

